Evolus Inc (NASDAQ: EOLS) closed the day trading at $13.95 down -0.21% from the previous closing price of $13.98. In other words, the price has decreased by -$0.03 from its previous closing price. On the day, 890289 shares were traded.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Ratios:
For a better understanding of EOLS, let’s look at its different ratios. For the most recent quarter (mrq), Quick Ratio is recorded 2.10 and its Current Ratio is at 2.33.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on January 29, 2024, Upgraded its rating to Overweight and sets its target price to $16 from $10 previously.
On June 23, 2022, Needham started tracking the stock assigning a Buy rating and target price of $18.
Barclays Upgraded its Underweight to Equal Weight on May 12, 2022, whereas the target price for the stock was revised from $8 to $10.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Feb 22 ’24 when MOATAZEDI DAVID sold 7,706 shares for $13.08 per share. The transaction valued at 100,804 led to the insider holds 792,416 shares of the business.
Beaver Sandra sold 1,821 shares of EOLS for $23,821 on Feb 22 ’24. The Chief Financial Officer now owns 159,873 shares after completing the transaction at $13.08 per share. On Feb 22 ’24, another insider, Avelar Rui, who serves as the insider of the company, sold 1,821 shares for $13.08 each. As a result, the insider received 23,821 and left with 399,891 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EOLS now has a Market Capitalization of 857.89M and an Enterprise Value of 921.60M. For the stock, the TTM Price-to-Sale (P/S) ratio is 4.25. Its current Enterprise Value per Revenue stands at 4.56 whereas that against EBITDA is -22.04.
Stock Price History:
Over the past 52 weeks, EOLS has reached a high of $15.43, while it has fallen to a 52-week low of $7.07. The 50-Day Moving Average of the stock is 13.17, while the 200-Day Moving Average is calculated to be 9.95.
Shares Statistics:
Over the past 3-months, EOLS traded about 637.48K shares per day on average, while over the past 10 days, EOLS traded about 884.6k shares per day. A total of 57.82M shares are outstanding, with a floating share count of 47.34M. Insiders hold about 23.03% of the company’s shares, while institutions hold 74.97% stake in the company. Shares short for EOLS as of Feb 29, 2024 were 4.96M with a Short Ratio of 7.78, compared to 4.76M on Jan 31, 2024. Therefore, it implies a Short% of Shares Outstanding of 8.58% and a Short% of Float of 8.72%.
Earnings Estimates
Current recommendations for the stock of the company come from 4 analysts. On average, analysts expect EPS of -$0.1 for the current quarter, with a high estimate of -$0.05 and a low estimate of -$0.2, while EPS last year was -$0.15. The consensus estimate for the next quarter is -$0.06, with high estimates of -$0.03 and low estimates of -$0.09.
Analysts are recommending an EPS of between -$0.18 and -$0.49 for the fiscal current year, implying an average EPS of -$0.35. EPS for the following year is $0.16, with 4 analysts recommending between $0.3 and $0.05.
Revenue Estimates
6 analysts predict $57.32M in revenue for the current quarter. It ranges from a high estimate of $60.88M to a low estimate of $55.2M. As of the current estimate, Evolus Inc’s year-ago sales were $41.72M, an estimated increase of 37.40% from the year-ago figure. For the next quarter, 6 analysts are estimating revenue of $66.07M, an increase of 33.90% less than the figure of $37.40% in the same quarter last year. There is a high estimate of $68M for the next quarter, whereas the lowest estimate is $64.2M.
A total of 7 analysts have provided revenue estimates for EOLS’s current fiscal year. The highest revenue estimate was $264.34M, while the lowest revenue estimate was $256.7M, resulting in an average revenue estimate of $260.91M. In the same quarter a year ago, actual revenue was $202.09M, up 29.10% from the average estimate. Based on 7 analysts’ estimates, the company’s revenue will be $345.89M in the next fiscal year. The high estimate is $371M and the low estimate is $327.68M. The average revenue growth estimate for next year is up 32.60% from the average revenue estimate for this year.
